137 related articles for article (PubMed ID: 1689784)
21. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
Habib FK; Lee IR; Stitch SR; Smith PH
J Endocrinol; 1976 Oct; 71(1):99-107. PubMed ID: 62008
[TBL] [Abstract][Full Text] [Related]
22. Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
Wright F; Poizat R; Bongini M; Bozzolan F; Doukani A; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1985 Feb; 60(2):294-8. PubMed ID: 2578133
[TBL] [Abstract][Full Text] [Related]
23. New approaches for the treatment of prostatic hypertrophy and cancer.
Zoppi S; Cocconi M; Serio M; Martini L; Motta M
Horm Res; 1987; 28(2-4):250-60. PubMed ID: 2456974
[TBL] [Abstract][Full Text] [Related]
24. Correlated biochemical and stereological studies on testosterone metabolism in the stromal and epithelial compartment of human benign prostatic hyperplasia.
Schweikert HU; Totzauer P; Rohr HP; Bartsch G
J Urol; 1985 Aug; 134(2):403-7. PubMed ID: 2410636
[TBL] [Abstract][Full Text] [Related]
25. Studies of the nuclear 5 alpha-reductase of human hyperplastic prostatic tissue.
Hudson RW
J Steroid Biochem; 1981 Jun; 14(6):579-84. PubMed ID: 6165865
[No Abstract] [Full Text] [Related]
26. (De)phosphorylation agents influence 5 alpha-reduction of testosterone in human prostate.
Le Goff JM; Martin PM; Raynaud JP
Endocrinology; 1988 Sep; 123(3):1693-5. PubMed ID: 2456919
[TBL] [Abstract][Full Text] [Related]
27. Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia.
Tsugaya M; Habib FK; Chisholm GD; Ross M; Tozawa K; Hayashi Y; Kohri K; Tanaka S
Urol Res; 1996; 24(5):265-71. PubMed ID: 8931290
[TBL] [Abstract][Full Text] [Related]
28. Androgen receptors in male sex tissues of rats and humans.
Attramadal A; Weddington SC; Naess O; Djoseland O; Hansson V
Prog Clin Biol Res; 1976; 6():189-203. PubMed ID: 66689
[TBL] [Abstract][Full Text] [Related]
29. The concentrations of the endogenous C19-steroids in hyperplastic prostatic tissue and the effect of finasteride treatment.
Hill M; Petrik R; Hampl R; Stárka L
Horm Metab Res; 1996 Oct; 28(10):562-4. PubMed ID: 8934217
[TBL] [Abstract][Full Text] [Related]
30. Human prostatic cells in culture: different testosterone metabolic profile in epithelial cells and fibroblasts from normal or hyperplastic prostates.
Berthaut I; Portois MC; Cussenot O; Mowszowicz I
J Steroid Biochem Mol Biol; 1996 May; 58(2):235-42. PubMed ID: 8809206
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
Krieg M; Bartsch W; Janssen W; Voigt KD
J Steroid Biochem; 1979 Jul; 11(1B):615-24. PubMed ID: 90754
[No Abstract] [Full Text] [Related]
32. Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues.
Hammond GL
J Endocrinol; 1978 Jul; 78(1):7-19. PubMed ID: 79632
[TBL] [Abstract][Full Text] [Related]
33. 5alpha-reductase and 17beta-hydroxysteroid dehydrogenase expression in epithelial cells from hyperplastic and malignant human prostate.
Délos S; Carsol JL; Fina F; Raynaud JP; Martin PM
Int J Cancer; 1998 Mar; 75(6):840-6. PubMed ID: 9506528
[TBL] [Abstract][Full Text] [Related]
34. Studies on the possible existence of two 5 alpha-reductases in the rat prostate.
Martini L; Zoppi S; Motta M
J Steroid Biochem; 1986 Jan; 24(1):177-82. PubMed ID: 3702403
[TBL] [Abstract][Full Text] [Related]
35. Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
Baranowska B; Zgliczyński S
Nuklearmedizin; 1979; 18(6):297-9. PubMed ID: 94161
[TBL] [Abstract][Full Text] [Related]
36. Characterization of type I 5 alpha-reductase activity in DU145 human prostatic adenocarcinoma cells.
Kaefer M; Audia JE; Bruchovsky N; Goode RL; Hsiao KC; Leibovitch IY; Krushinski JH; Lee C; Steidle CP; Sutkowski DM; Neubauer BL
J Steroid Biochem Mol Biol; 1996 May; 58(2):195-205. PubMed ID: 8809201
[TBL] [Abstract][Full Text] [Related]
37. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC
du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC
J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701
[TBL] [Abstract][Full Text] [Related]
38. The role of dihydrotestosterone in benign prostatic hyperplasia.
Carson C; Rittmaster R
Urology; 2003 Apr; 61(4 Suppl 1):2-7. PubMed ID: 12657354
[TBL] [Abstract][Full Text] [Related]
39. Nicotine and cotinine effects on 3 alpha hydroxysteroid dehydrogenase in canine prostate.
Meikle AW; Liu XH; Taylor GN; Stringham JD
Life Sci; 1988; 43(23):1845-50. PubMed ID: 3200111
[TBL] [Abstract][Full Text] [Related]
40. Androgen metabolism in different target tissues.
Martini L; Celotti F; Lechuga MJ; Melcangi RC; Motta M; Negri-Cesi P; Poletti A; Zoppi S
Ann N Y Acad Sci; 1990; 595():184-98. PubMed ID: 1695827
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
